Health & Biosciences — Adjusted Operating EBITDA
International Flavors & Fragrances Health & Biosciences — Adjusted Operating EBITDA increased by 2.0% to $153.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.9%, from $138.00M to $153.00M. Over 2 years (FY 2021 to FY 2023), Health & Biosciences — Adjusted Operating EBITDA shows relatively stable performance with a -3.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher EBITDA indicates stronger operational performance and cash flow generation potential.
Detailed definition
A measure of the segment's operating profitability, calculated by taking earnings before interest, taxes, depreciation,...
Peer comparison
The primary metric used by investors to compare segment-level profitability across peers.
iff_segment_health_biosciences_adjusted_operating_ebitdaHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $190.00M | $151.00M | $156.00M | $192.00M | $184.00M | $137.00M | $121.00M | $131.00M | $145.00M | $150.00M | $162.00M | $138.00M | $151.00M | $152.00M | $138.00M | $151.00M | $150.00M | $153.00M |
| QoQ Change | — | -20.5% | +3.3% | +23.1% | -4.2% | -25.5% | -11.7% | +8.3% | +10.7% | +3.4% | +8.0% | -14.8% | +9.4% | +0.7% | -9.2% | +9.4% | -0.7% | +2.0% |
| YoY Change | — | — | — | — | -3.2% | -9.3% | -22.4% | -31.8% | -21.2% | +9.5% | +33.9% | +5.3% | +4.1% | +1.3% | +0.0% | +0.0% | -1.3% | +10.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's health & biosciences — adjusted operating ebitda?
- International Flavors & Fragrances (IFF) reported health & biosciences — adjusted operating ebitda of $153.00M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — adjusted operating ebitda changed year-over-year?
- International Flavors & Fragrances's health & biosciences — adjusted operating ebitda increased by 10.9% year-over-year, from $138.00M to $153.00M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — adjusted operating ebitda?
- Over 2 years (2021 to 2023), International Flavors & Fragrances's health & biosciences — adjusted operating ebitda has grown at a -3.0% compound annual growth rate (CAGR), from $625.00M to $588.00M.
- What does health & biosciences — adjusted operating ebitda mean?
- The core operating profit of the segment, excluding non-cash and one-time items.